Sotera Health Company $SHC is MIG Capital LLC's Largest Position

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

MIG Capital LLC cut its holdings in Sotera Health Company (NASDAQ:SHC - Free Report) by 13.6% in the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 5,113,951 shares of the company's stock after selling 804,626 shares during the quarter. Sotera Health comprises 7.4% of MIG Capital LLC's holdings, making the stock its largest position. MIG Capital LLC owned 1.80% of Sotera Health worth $59,629,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Sculptor Capital LP purchased a new stake in Sotera Health in the fourth quarter valued at about $68,400,000. Dimensional Fund Advisors LP raised its stake in Sotera Health by 27.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,143,955 shares of the company's stock valued at $43,004,000 after buying an additional 673,979 shares during the last quarter. Irenic Capital Management LP raised its stake in Sotera Health by 4.3% in the fourth quarter. Irenic Capital Management LP now owns 2,909,163 shares of the company's stock valued at $39,797,000 after buying an additional 120,832 shares during the last quarter. Two Seas Capital LP raised its stake in Sotera Health by 624.0% in the fourth quarter. Two Seas Capital LP now owns 2,896,136 shares of the company's stock valued at $39,619,000 after buying an additional 2,496,136 shares during the last quarter. Finally, D. E. Shaw & Co. Inc. raised its stake in Sotera Health by 140.8% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 2,624,750 shares of the company's stock valued at $35,907,000 after buying an additional 1,534,666 shares during the last quarter. 91.03% of the stock is currently owned by hedge funds and other institutional investors.

Sotera Health Stock Performance

Shares of Sotera Health stock traded up $0.50 on Friday, reaching $16.43. 1,302,737 shares of the stock were exchanged, compared to its average volume of 1,655,172. The company has a quick ratio of 2.23, a current ratio of 2.47 and a debt-to-equity ratio of 4.49. Sotera Health Company has a twelve month low of $9.53 and a twelve month high of $17.08. The firm has a market capitalization of $4.67 billion, a price-to-earnings ratio of 205.40 and a beta of 1.81. The business has a 50 day moving average price of $12.35 and a two-hundred day moving average price of $12.15.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its earnings results on Friday, August 8th. The company reported $0.20 EPS for the quarter, topping analysts' consensus estimates of $0.17 by $0.03. The firm had revenue of $294.34 million during the quarter, compared to the consensus estimate of $275.81 million. Sotera Health had a return on equity of 39.42% and a net margin of 2.14%.The company's revenue was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.19 earnings per share. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. Analysts anticipate that Sotera Health Company will post 0.61 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms have commented on SHC. Wall Street Zen upgraded Sotera Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 16th. Barclays reaffirmed an "overweight" rating on shares of Sotera Health in a report on Friday, August 8th. Finally, The Goldman Sachs Group raised Sotera Health from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $14.00 to $17.00 in a report on Monday, May 5th. Four investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $16.00.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.